In glioblastoma multiforme (GBM) and chondrosarcoma—both of which are historically “immune-cold” tumors with limited T-cell infiltration, poor immunogenicity, and restricted therapeutic responsiveness—ALT positivity has been associated with improved patient outcomes. The gene discussed is GPT; the disease is glioblastoma.